NewslettersCancer Stem Cell NewsHematopoiesis NewsMetabolic Adaptation to Tyrosine Kinase Inhibition in Leukemia Stem CellsBy Noshin Noorjahan - May 24, 20230129Researchers performed a comprehensive evaluation of metabolic adaptation to tyrosine kinase inhibitor treatment and its role in chronic myelogenous leukemia hematopoietic stem and progenitor cell persistence.[Blood]Abstract